Stay updated on Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange Detected- Updated region name from Rhone-Alpes to Auvergne-Rhône-Alpes and added corresponding address. - Bumped revision from v3.1.0 to v3.2.0. - Added a status notice about government funding and NIH Clinical Center operations.SummaryDifference3%

- Check27 days agoChange DetectedThe page is updated to a newer revision (v3.1.0) with current dates (September 2025) and removes older revision/date markers (v3.0.2 and prior dates). This indicates a fresh release and updated time-related information.SummaryDifference0.2%

- Check34 days agoChange DetectedUpdates the citation metadata: changes the publication date, adds an online-ahead-of-print note, and adjusts the DOI/format.SummaryDifference0.2%

- Check41 days agoChange DetectedLocation naming updated to Respublika and Kazan, Tatarstan; maximum duration extended to 58 months; revision bumped to v3.0.2 with an estimated last-update flag and new dates added.SummaryDifference0.4%

- Check48 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.1%

- Check56 days agoChange DetectedThe webpage has undergone significant updates, including the addition of numerous locations across various countries and the inclusion of drug information for specific medications, while also removing outdated location references and some drug information.SummaryDifference16%

Stay in the know with updates to Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.